Portage Biotech Ownership 2024 | Who Owns Portage Biotech Now?
Institutional Ownership
1.39%
Insider Ownership
36.40%
Retail Ownership
62.21%
Institutional Holders
3.00
Portage Biotech Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 7.19% | 0.00% | 1,501,780 | -164,105 | -9.85% | 318,678 | Jun 30, 2024 |
| BISON WEALTH, LLC | 1.02% | 0.02% | 213,398 | - | - | 120,207 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.36% | - | 75,800 | 44,137 | 139.40% | 16,085 | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | 0.26% | - | 55,263 | - | - | 11,727 | Jun 30, 2024 |
| IEQ CAPITAL, LLC | 0.08% | - | 16,650 | - | - | 3,533 | Jun 30, 2024 |
| PATHSTONE HOLDINGS, LLC | 0.05% | - | 10,100 | - | - | 2,143 | Jun 30, 2024 |
| UBS GROUP AG | 0.04% | - | 9,158 | 5,620 | 158.85% | 1,941 | Jun 30, 2024 |
| BLACKROCK INC. | 0.04% | - | 8,203 | -23,070 | -73.77% | 1,741 | Jun 30, 2024 |
| MORGAN STANLEY | 0.01% | - | 2,497 | 497 | 24.85% | 530 | Jun 30, 2024 |
| CAROLINAS WEALTH CONSULTING LLC | 0.01% | 0.00% | 1,515 | 1,515 | 100.00% | 322 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.01% | - | 1,455 | - | - | 276 | Jun 30, 2024 |
| CREDIT AGRICOLE S A | 0.01% | - | 1,350 | - | - | 286 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 700 | - | - | 149 | Jun 30, 2024 |
| PRINCETON GLOBAL ASSET MANAGEMENT LLC | 0.00% | - | 150 | - | - | 32 | Jun 30, 2024 |
| ABICH FINANCIAL WEALTH MANAGEMENT LLC | 0.00% | - | 60 | - | - | 13 | Jun 30, 2024 |
| TORONTO DOMINION BANK | - | - | 7 | - | - | 1 | Jun 30, 2024 |
| BROWN BROTHERS HARRIMAN & CO | - | - | - | -14,000 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -1,649 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -32,827 | -100.00% | - | Jun 30, 2024 |
| SIGMA PLANNING CORP | - | - | - | -10,680 | -100.00% | - | Jun 30, 2024 |
Portage Biotech's largest institutional shareholder is ARMISTICE CAPITAL, LLC, holding 7.19% of the company's total share outstanding, currently valued at $318.68K. The top 10 institutional shareholders own together 9.07% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BISON WEALTH, LLC | 1.02% | 0.02% | 213,398 | - | - | 120,207 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 7.19% | 0.00% | 1,501,780 | -164,105 | -9.85% | 318,678 | Jun 30, 2024 |
| CAROLINAS WEALTH CONSULTING LLC | 0.01% | 0.00% | 1,515 | 1,515 | 100.00% | 322 | Jun 30, 2024 |
| IEQ CAPITAL, LLC | 0.08% | - | 16,650 | - | - | 3,533 | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | 0.26% | - | 55,263 | - | - | 11,727 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.36% | - | 75,800 | 44,137 | 139.40% | 16,085 | Jun 30, 2024 |
| PATHSTONE HOLDINGS, LLC | 0.05% | - | 10,100 | - | - | 2,143 | Jun 30, 2024 |
| ABICH FINANCIAL WEALTH MANAGEMENT LLC | 0.00% | - | 60 | - | - | 13 | Jun 30, 2024 |
| PRINCETON GLOBAL ASSET MANAGEMENT LLC | 0.00% | - | 150 | - | - | 32 | Jun 30, 2024 |
| CREDIT AGRICOLE S A | 0.01% | - | 1,350 | - | - | 286 | Jun 30, 2024 |
| UBS GROUP AG | 0.04% | - | 9,158 | 5,620 | 158.85% | 1,941 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.01% | - | 1,455 | - | - | 276 | Jun 30, 2024 |
| MORGAN STANLEY | 0.01% | - | 2,497 | 497 | 24.85% | 530 | Jun 30, 2024 |
| BLACKROCK INC. | 0.04% | - | 8,203 | -23,070 | -73.77% | 1,741 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 700 | - | - | 149 | Jun 30, 2024 |
| TORONTO DOMINION BANK | - | - | 7 | - | - | 1 | Jun 30, 2024 |
| BROWN BROTHERS HARRIMAN & CO | - | - | - | -14,000 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -1,649 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -32,827 | -100.00% | - | Jun 30, 2024 |
| SIGMA PLANNING CORP | - | - | - | -10,680 | -100.00% | - | Jun 30, 2024 |
The largest Portage Biotech shareholder by % of total assets is BISON WEALTH, LLC. The company owns 213.40K shares of Portage Biotech (PRTG), representing 0.02% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 0.36% | - | 75,800 | 44,137 | 139.40% | 16,085 | Jun 30, 2024 |
| UBS GROUP AG | 0.04% | - | 9,158 | 5,620 | 158.85% | 1,941 | Jun 30, 2024 |
| CAROLINAS WEALTH CONSULTING LLC | 0.01% | 0.00% | 1,515 | 1,515 | 100.00% | 322 | Jun 30, 2024 |
| MORGAN STANLEY | 0.01% | - | 2,497 | 497 | 24.85% | 530 | Jun 30, 2024 |
| TORONTO DOMINION BANK | - | - | 7 | - | - | 1 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 700 | - | - | 149 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.01% | - | 1,455 | - | - | 276 | Jun 30, 2024 |
| CREDIT AGRICOLE S A | 0.01% | - | 1,350 | - | - | 286 | Jun 30, 2024 |
| PRINCETON GLOBAL ASSET MANAGEMENT LLC | 0.00% | - | 150 | - | - | 32 | Jun 30, 2024 |
| ABICH FINANCIAL WEALTH MANAGEMENT LLC | 0.00% | - | 60 | - | - | 13 | Jun 30, 2024 |
| PATHSTONE HOLDINGS, LLC | 0.05% | - | 10,100 | - | - | 2,143 | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | 0.26% | - | 55,263 | - | - | 11,727 | Jun 30, 2024 |
| IEQ CAPITAL, LLC | 0.08% | - | 16,650 | - | - | 3,533 | Jun 30, 2024 |
| BISON WEALTH, LLC | 1.02% | 0.02% | 213,398 | - | - | 120,207 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -1,649 | -100.00% | - | Jun 30, 2024 |
| SIGMA PLANNING CORP | - | - | - | -10,680 | -100.00% | - | Jun 30, 2024 |
| BEACON INVESTMENT ADVISORY SERVICES, INC. | - | - | - | -11,395 | -100.00% | - | Jun 30, 2024 |
| BROWN BROTHERS HARRIMAN & CO | - | - | - | -14,000 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -15,957 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Portage Biotech's largest institutional buyer is RENAISSANCE TECHNOLOGIES LLC. The company purchased 44.14K stocks of PRTG, valued at $16.09K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 7.19% | 0.00% | 1,501,780 | -164,105 | -9.85% | 318,678 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -32,827 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | 0.04% | - | 8,203 | -23,070 | -73.77% | 1,741 | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -15,957 | -100.00% | - | Jun 30, 2024 |
| BROWN BROTHERS HARRIMAN & CO | - | - | - | -14,000 | -100.00% | - | Jun 30, 2024 |
| BEACON INVESTMENT ADVISORY SERVICES, INC. | - | - | - | -11,395 | -100.00% | - | Jun 30, 2024 |
| SIGMA PLANNING CORP | - | - | - | -10,680 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -1,649 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
| BISON WEALTH, LLC | 1.02% | 0.02% | 213,398 | - | - | 120,207 | Jun 30, 2024 |
| IEQ CAPITAL, LLC | 0.08% | - | 16,650 | - | - | 3,533 | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | 0.26% | - | 55,263 | - | - | 11,727 | Jun 30, 2024 |
| PATHSTONE HOLDINGS, LLC | 0.05% | - | 10,100 | - | - | 2,143 | Jun 30, 2024 |
| ABICH FINANCIAL WEALTH MANAGEMENT LLC | 0.00% | - | 60 | - | - | 13 | Jun 30, 2024 |
| PRINCETON GLOBAL ASSET MANAGEMENT LLC | 0.00% | - | 150 | - | - | 32 | Jun 30, 2024 |
| CREDIT AGRICOLE S A | 0.01% | - | 1,350 | - | - | 286 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.01% | - | 1,455 | - | - | 276 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 700 | - | - | 149 | Jun 30, 2024 |
| TORONTO DOMINION BANK | - | - | 7 | - | - | 1 | Jun 30, 2024 |
| MORGAN STANLEY | 0.01% | - | 2,497 | 497 | 24.85% | 530 | Jun 30, 2024 |
As of Jun 30 2024, Portage Biotech's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -0.16M shares of PRTG, valued at $318.68K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CAROLINAS WEALTH CONSULTING LLC | 0.01% | 0.00% | 1,515 | 1,515 | 100.00% | 322 | Jun 30, 2024 |
Portage Biotech's largest new institutional shareholder by number of shares is CAROLINAS WEALTH CONSULTING LLC, purchased 1.51K shares, valued at $322.00, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | - | - | - | -32,827 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -15,957 | -100.00% | - | Jun 30, 2024 |
| BROWN BROTHERS HARRIMAN & CO | - | - | - | -14,000 | -100.00% | - | Jun 30, 2024 |
| BEACON INVESTMENT ADVISORY SERVICES, INC. | - | - | - | -11,395 | -100.00% | - | Jun 30, 2024 |
| SIGMA PLANNING CORP | - | - | - | -10,680 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -1,649 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -4 | -100.00% | - | Jun 30, 2024 |
Portage Biotech's largest sold out institutional shareholder by shares sold is MILLENNIUM MANAGEMENT LLC, sold -32.83K shares, valued at -, as of undefined.
Portage Biotech Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| GPS Funds I | 0.00% | 1,485 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 871 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 8,189 | - | - | Feb 29, 2024 |
| Global X Funds | 0.00% | 1,492 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 74 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 2,622 | - | - | Mar 28, 2024 |
| ProFunds | 0.00% | 107 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 17,258 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 4,979 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 5,644 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 32 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 144 | - | - | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 416 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 1,541 | - | - | Mar 31, 2024 |
| Investment Managers Series Trust | 0.00% | 281 | - | - | Mar 31, 2024 |
Portage Biotech's largest mutual fund holder by % of total assets is "GPS Funds I", owning 1.49K shares, compromising 0.00% of its total assets.
Portage Biotech Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -86.96% |
| 31 Mar, 24 | 23 | 15.00% |
| 31 Dec, 23 | 20 | 5.26% |
| 30 Sep, 23 | 19 | -5.00% |
| 30 Jun, 23 | 20 | 11.11% |
| 31 Mar, 23 | 18 | -5.26% |
| 31 Dec, 22 | 19 | 5.56% |
| 30 Sep, 22 | 18 | -21.74% |
| 30 Jun, 22 | 23 | -20.69% |
| 31 Mar, 22 | 29 | 16.00% |
| 31 Dec, 21 | 25 | -13.79% |
| 30 Sep, 21 | 29 | 7.41% |
| 30 Jun, 21 | 27 | 285.71% |
| 31 Mar, 21 | 7 | - |
As of 30 Jun 24, 3 institutions are holding Portage Biotech's shares, representing a decrease of -86.96% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 290,653 | -86.44% |
| 31 Mar, 24 | 2,142,890 | -5.46% |
| 31 Dec, 23 | 2,266,747 | -1.26% |
| 30 Sep, 23 | 2,295,637 | 543.82% |
| 30 Jun, 23 | 356,563 | 109.24% |
| 31 Mar, 23 | 170,410 | 4.01% |
| 31 Dec, 22 | 163,845 | 44.25% |
| 30 Sep, 22 | 113,581 | -31.16% |
| 30 Jun, 22 | 165,000 | -67.21% |
| 31 Mar, 22 | 503,167 | -17.51% |
| 31 Dec, 21 | 609,979 | -18.96% |
| 30 Sep, 21 | 752,728 | -20.41% |
| 30 Jun, 21 | 945,775 | 2942.54% |
| 31 Mar, 21 | 31,085 | - |
Portage Biotech (PRTG) has 290.65K shares outstanding as of 30 Jun 24, down -86.44% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 1.39% | 1.32% |
| 31 Mar, 24 | 10.25% | 6.32% |
| 31 Dec, 23 | 12.73% | 7.57% |
| 30 Sep, 23 | 12.97% | 296.16% |
| 30 Jun, 23 | 2.09% | 209.22% |
| 31 Mar, 23 | 1.00% | 108.16% |
| 31 Dec, 22 | 0.96% | 208.93% |
| 30 Sep, 22 | 0.68% | 44.41% |
| 30 Jun, 22 | 1.24% | 8.33% |
| 31 Mar, 22 | 3.85% | 18.44% |
| 31 Dec, 21 | 4.57% | 14.34% |
| 30 Sep, 21 | 5.65% | 9.42% |
| 30 Jun, 21 | 7.74% | 11034.24% |
| 31 Mar, 21 | 0.26% | - |
As of 30 Jun 24, Portage Biotech is held by 1.39% institutional shareholders, representing a 1.32% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 1 | -91.67% |
| 31 Mar, 24 | 12 | 100.00% |
| 31 Dec, 23 | 6 | 50.00% |
| 30 Sep, 23 | 4 | -50.00% |
| 30 Jun, 23 | 8 | 100.00% |
| 31 Mar, 23 | 4 | -63.64% |
| 31 Dec, 22 | 11 | 120.00% |
| 30 Sep, 22 | 5 | -58.33% |
| 30 Jun, 22 | 12 | -7.69% |
| 31 Mar, 22 | 13 | -7.14% |
| 31 Dec, 21 | 14 | -22.22% |
| 30 Sep, 21 | 18 | -30.77% |
| 30 Jun, 21 | 26 | 271.43% |
| 31 Mar, 21 | 7 | - |
1 institutional shareholders have increased their position in PRTG stock as of 30 Jun 24 compared to 12 in the previous quarter (a -91.67% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | - | -100.00% |
| 31 Mar, 24 | 2 | -66.67% |
| 31 Dec, 23 | 6 | - |
| 30 Sep, 23 | 6 | 200.00% |
| 30 Jun, 23 | 2 | -66.67% |
| 31 Mar, 23 | 6 | 100.00% |
| 31 Dec, 22 | 3 | -57.14% |
| 30 Sep, 22 | 7 | -22.22% |
| 30 Jun, 22 | 9 | -18.18% |
| 31 Mar, 22 | 11 | 120.00% |
| 31 Dec, 21 | 5 | -28.57% |
| 30 Sep, 21 | 7 | - |
| 30 Jun, 21 | - | - |
| 31 Mar, 21 | - | - |
- institutional shareholders have reduced their position in PRTG stock as of 30 Jun 24 compared to 2 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 3 | -86.96% | 290,653 | -86.44% | 1.39% | 1.32% | 1 | -91.67% | - | -100.00% |
| 31 Mar, 24 | 23 | 15.00% | 2,142,890 | -5.46% | 10.25% | 6.32% | 12 | 100.00% | 2 | -66.67% |
| 31 Dec, 23 | 20 | 5.26% | 2,266,747 | -1.26% | 12.73% | 7.57% | 6 | 50.00% | 6 | - |
| 30 Sep, 23 | 19 | -5.00% | 2,295,637 | 543.82% | 12.97% | 296.16% | 4 | -50.00% | 6 | 200.00% |
| 30 Jun, 23 | 20 | 11.11% | 356,563 | 109.24% | 2.09% | 209.22% | 8 | 100.00% | 2 | -66.67% |
| 31 Mar, 23 | 18 | -5.26% | 170,410 | 4.01% | 1.00% | 108.16% | 4 | -63.64% | 6 | 100.00% |
| 31 Dec, 22 | 19 | 5.56% | 163,845 | 44.25% | 0.96% | 208.93% | 11 | 120.00% | 3 | -57.14% |
| 30 Sep, 22 | 18 | -21.74% | 113,581 | -31.16% | 0.68% | 44.41% | 5 | -58.33% | 7 | -22.22% |
| 30 Jun, 22 | 23 | -20.69% | 165,000 | -67.21% | 1.24% | 8.33% | 12 | -7.69% | 9 | -18.18% |
| 31 Mar, 22 | 29 | 16.00% | 503,167 | -17.51% | 3.85% | 18.44% | 13 | -7.14% | 11 | 120.00% |
| 31 Dec, 21 | 25 | -13.79% | 609,979 | -18.96% | 4.57% | 14.34% | 14 | -22.22% | 5 | -28.57% |
| 30 Sep, 21 | 29 | 7.41% | 752,728 | -20.41% | 5.65% | 9.42% | 18 | -30.77% | 7 | - |
| 30 Jun, 21 | 27 | 285.71% | 945,775 | 2942.54% | 7.74% | 11034.24% | 26 | 271.43% | - | - |
| 31 Mar, 21 | 7 | - | 31,085 | - | 0.26% | - | 7 | - | - | - |
Portage Biotech Peer Ownership
| Ticker | Company |
|---|---|
| FREQ | Korro Bio, Inc. |
| CUE | Cue Biopharma, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| ARVN | Arvinas, Inc. |
| VECT | VectivBio Holding AG |
| DBTX | Decibel Therapeutics, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| AVTE | Aerovate Therapeutics, Inc. |
| FENC | Fennec Pharmaceuticals Inc. |
| JANX | Janux Therapeutics, Inc. |
| INZY | Inozyme Pharma, Inc. |
| KROS | Keros Therapeutics, Inc. |
| HRMY | Harmony Biosciences Holdings, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| KRTX | Karuna Therapeutics, Inc. |
| ELYM | Eliem Therapeutics, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
PRTG Ownership FAQ
Who Owns Portage Biotech?
Portage Biotech is owned by institutional shareholders (1.39%), insiders (36.40%), and public (62.21%). The largest institutional shareholder of Portage Biotech is ARMISTICE CAPITAL, LLC (7.19% of total shares) and the top mutual fund owner is GPS Funds I (0.00% of total shares).
Who are the major institutional shareholders of Portage Biotech?
Portage Biotech's major institutional shareholders are ARMISTICE CAPITAL, LLC, BISON WEALTH, LLC, RENAISSANCE TECHNOLOGIES LLC, PEAK6 INVESTMENTS LLC, and IEQ CAPITAL, LLC. The top five shareholders own together 8.91% of the company's share outstanding.
How many Portage Biotech shareholders are there?
As of Jun 2024, there are 3 institutional shareholders of Portage Biotech.
What percentage of Portage Biotech is owned by ARMISTICE CAPITAL, LLC?
ARMISTICE CAPITAL, LLC owns 1.5M shares of Portage Biotech, representing 7.19% of the company's total shares outstanding, valued at $318.68K (as of Jun 2024).
What percentage of Portage Biotech is owned by BISON WEALTH, LLC?
As of Jun 2024, BISON WEALTH, LLC holds 213.4K shares of Portage Biotech (PRTG), compromising 1.02% of the company, valued at $120.21K.
What percentage of Portage Biotech is owned by RENAISSANCE TECHNOLOGIES LLC?
RENAISSANCE TECHNOLOGIES LLC is the third largest holder of Portage Biotech. The company owns 75.8K of the company's shares outstanding (worth $16.08K).